{"transactions":[{"id":4635654,"issuer":{"id":7122,"kind":"organization","name":"Xilio Therapeutics, Inc."},"owners":[{"id":184215,"kind":"person","name":"Houvras Yariv","position":1,"cik":"0002154870","reported_name":"Houvras Yariv","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-10-03T00:33:12.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on October 1, 2026 and will vest with respect to 25% of the shares of common stock underlying the stock option on September 28, 2027, and the remaining 75% of the shares of common stock underlying the stock option will continue to vest in 36 equal monthly installments thereafter."}],"balance_after":105000,"derivative":{"exercise_price":8.91,"expiration_date":"2036-09-30","underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001193125-26-412466","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1840233/000119312526412466/ownership.xml","form_type":"4"}}]}